• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌作为对抗幽门螺杆菌胃部感染的活体微生物战士。

Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections.

机构信息

Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.

出版信息

BMC Gastroenterol. 2021 Oct 20;21(1):388. doi: 10.1186/s12876-021-01977-1.

DOI:10.1186/s12876-021-01977-1
PMID:34670526
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8527827/
Abstract

BACKGROUND

Helicobacter pylori (H. pylori) is the causative agent of stomach diseases such as duodenal ulcer and gastric cancer, in this regard incomplete eradication of this bacterium has become to a serious concern. Probiotics are a group of the beneficial bacteria which increase the cure rate of H. pylori infections through various mechanisms such as competitive inhibition, co-aggregation ability, enhancing mucus production, production of bacteriocins, and modulating immune response.

RESULT

In this study, according to the received articles, the anti-H. pylori activities of probiotics were reviewed. Based on studies, administration of standard antibiotic therapy combined with probiotics plays an important role in the effective treatment of H. pylori infection. According to the literature, Lactobacillus casei, Lactobacillus reuteri, Lactobacillus rhamnosus GG, and Saccharomyces boulardii can effectively eradicate H. pylori infection. Our results showed that in addition to decrease gastrointestinal symptoms, probiotics can reduce the side effects of antibiotics (especially diarrhea) by altering the intestinal microbiome.

CONCLUSION

Nevertheless, antagonist activities of probiotics are H. pylori strain-specific. In general, these bacteria can be used for therapeutic purposes such as adjuvant therapy, drug-delivery system, as well as enhancing immune system against H. pylori infection.

摘要

背景

幽门螺杆菌(H. pylori)是十二指肠溃疡和胃癌等胃部疾病的病原体,在这方面,这种细菌的不完全根除已成为一个严重的问题。益生菌是一组有益细菌,通过竞争抑制、共聚集能力、增强黏液产生、产生细菌素和调节免疫反应等多种机制提高 H. pylori 感染的治愈率。

结果

在这项研究中,根据收到的文章,综述了益生菌的抗 H. pylori 活性。基于研究,标准抗生素治疗联合益生菌的给药在有效治疗 H. pylori 感染方面发挥着重要作用。根据文献,干酪乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌 GG 和布拉氏酵母菌可有效根除 H. pylori 感染。我们的结果表明,除了减轻胃肠道症状外,益生菌还可以通过改变肠道微生物群来减少抗生素的副作用(尤其是腹泻)。

结论

然而,益生菌的拮抗活性是 H. pylori 菌株特异性的。总的来说,这些细菌可用于治疗目的,如辅助治疗、药物递送系统以及增强免疫系统对抗 H. pylori 感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402e/8527827/ede5f5a56f6b/12876_2021_1977_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402e/8527827/a738dc8c5426/12876_2021_1977_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402e/8527827/ede5f5a56f6b/12876_2021_1977_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402e/8527827/a738dc8c5426/12876_2021_1977_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402e/8527827/ede5f5a56f6b/12876_2021_1977_Fig2_HTML.jpg

相似文献

1
Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections.益生菌作为对抗幽门螺杆菌胃部感染的活体微生物战士。
BMC Gastroenterol. 2021 Oct 20;21(1):388. doi: 10.1186/s12876-021-01977-1.
2
Are probiotics useful in Helicobacter pylori eradication?益生菌对根除幽门螺杆菌有用吗?
World J Gastroenterol. 2015 Oct 7;21(37):10644-53. doi: 10.3748/wjg.v21.i37.10644.
3
Probiotics in Helicobacter pylori-induced peptic ulcer disease.幽门螺杆菌诱导的消化性溃疡疾病中的益生菌
Best Pract Res Clin Gastroenterol. 2016 Feb;30(1):99-109. doi: 10.1016/j.bpg.2015.12.003. Epub 2015 Dec 18.
4
Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children: a systematic review and network meta-analysis.补充益生菌的三联疗法根除儿童幽门螺杆菌的疗效和安全性:一项系统评价和网状Meta分析
Eur J Clin Pharmacol. 2017 Oct;73(10):1199-1208. doi: 10.1007/s00228-017-2291-6. Epub 2017 Jul 5.
5
The impacts of probiotics in eradication therapy of Helicobacter pylori.益生菌对幽门螺杆菌根除治疗的影响。
Arch Microbiol. 2022 Nov 7;204(12):692. doi: 10.1007/s00203-022-03314-w.
6
The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.益生菌在幽门螺杆菌根除治疗期间对肠道微生物群的影响:随机对照试验。
Helicobacter. 2016 Jun;21(3):165-74. doi: 10.1111/hel.12270. Epub 2015 Sep 23.
7
Microbiota in the stomach and application of probiotics to gastroduodenal diseases.胃中的微生物群及益生菌在胃十二指肠疾病中的应用。
World J Gastroenterol. 2022 Dec 21;28(47):6702-6715. doi: 10.3748/wjg.v28.i47.6702.
8
Probiotics mitigate Helicobacter pylori-induced gastric inflammation and premalignant lesions in INS-GAS mice with the modulation of gastrointestinal microbiota.益生菌通过调节胃肠道微生物群减轻 INS-GAS 小鼠中幽门螺杆菌诱导的胃炎症和癌前病变。
Helicobacter. 2022 Aug;27(4):e12898. doi: 10.1111/hel.12898. Epub 2022 May 9.
9
Are probiotics useful for therapy of Helicobacter pylori diseases?益生菌对幽门螺杆菌病的治疗有用吗?
Comp Immunol Microbiol Infect Dis. 2019 Jun;64:99-108. doi: 10.1016/j.cimid.2019.02.010. Epub 2019 Mar 5.
10
Treating bugs with bugs: the role of probiotics as adjunctive therapy for Helicobacter pylori.以菌治菌:益生菌作为幽门螺杆菌辅助治疗的作用。
Ann Pharmacother. 2011 Jul;45(7-8):960-6. doi: 10.1345/aph.1Q104. Epub 2011 Jun 21.

引用本文的文献

1
Global Profile of Drug Resistance Related to Infection in Children: A Systematic Review and Meta-Analysis.儿童感染相关耐药性的全球概况:一项系统评价和荟萃分析
Health Sci Rep. 2025 Sep 14;8(9):e71238. doi: 10.1002/hsr2.71238. eCollection 2025 Sep.
2
Gut microbiota in gastric cancer: from pathogenesis to precision medicine.胃癌中的肠道微生物群:从发病机制到精准医学
Front Microbiol. 2025 Jul 30;16:1606924. doi: 10.3389/fmicb.2025.1606924. eCollection 2025.
3
The impact of infection and eradication therapies on gut microbiota: a systematic review of microbial dysbiosis and its implications in gastric carcinogenesis.

本文引用的文献

1
Rescue effects of -containing bismuth regimens after treatment failure.含铋剂方案在治疗失败后的挽救效果。
New Microbes New Infect. 2021 May 19;42:100904. doi: 10.1016/j.nmni.2021.100904. eCollection 2021 Jul.
2
Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges.益生菌、光生物调节与疾病管理:争议与挑战。
Int J Mol Sci. 2021 May 6;22(9):4942. doi: 10.3390/ijms22094942.
3
EPIYA motifs of genotypes and gastrointestinal diseases in the Iranian population: a systematic review and meta-analysis.
感染与根除疗法对肠道微生物群的影响:微生物失调及其在胃癌发生中的意义的系统评价
Front Cell Infect Microbiol. 2025 Jul 7;15:1592977. doi: 10.3389/fcimb.2025.1592977. eCollection 2025.
4
Towards Effective Eradication: Emerging Therapies in the Wake of Antibiotic Resistance.迈向有效根除:抗生素耐药性背景下的新兴疗法
Int J Mol Sci. 2025 Jun 24;26(13):6064. doi: 10.3390/ijms26136064.
5
Recommendations and Adjuvant Therapies to Mitigate Clarithromycin-Resistant -Associated Infections in Africa.减轻非洲地区克拉霉素耐药相关感染的建议及辅助治疗方法
Infect Drug Resist. 2025 Jun 26;18:3169-3174. doi: 10.2147/IDR.S528422. eCollection 2025.
6
Non-antibiotic therapies for multidrug-resistant gastrointestinal infections: an overview of the use of probiotics, natural compounds, and bacteriophages.多重耐药性胃肠道感染的非抗生素疗法:益生菌、天然化合物和噬菌体的应用概述
Front Antibiot. 2025 May 6;4:1554061. doi: 10.3389/frabi.2025.1554061. eCollection 2025.
7
Natural Products in the Management of Gastroesophageal Reflux Disease: Mechanisms, Efficacy, and Future Directions.天然产物在胃食管反流病管理中的应用:作用机制、疗效及未来方向
Nutrients. 2025 Mar 19;17(6):1069. doi: 10.3390/nu17061069.
8
Evaluating the Inhibitory Effects of Probiotic Bacteria and Propolis Extracts on the Growth and Histopathological Changes in Gastric Tissues of Challenged Wistar Rats.评估益生菌和蜂胶提取物对受攻击的Wistar大鼠胃组织生长及组织病理学变化的抑制作用。
Iran J Pharm Res. 2024 Dec 25;23(1):e148158. doi: 10.5812/ijpr-148158. eCollection 2024 Jan-Dec.
9
Efficacy of Pyloshot in combination with standard four-drug antimicrobial treatment for eradication: A randomized clinical trial.Pyloshot联合标准四联抗菌治疗根除幽门螺杆菌的疗效:一项随机临床试验。
JGH Open. 2024 Dec 8;8(12):e70046. doi: 10.1002/jgh3.70046. eCollection 2024 Dec.
10
Probiotic-based therapy as a new useful strategy for the treatment of patients with traumatic brain injury.基于益生菌的治疗方法作为一种治疗创伤性脑损伤患者的新的有效策略。
BMC Infect Dis. 2024 Nov 4;24(1):1240. doi: 10.1186/s12879-024-10146-0.
伊朗人群中基因型的EPIYA基序与胃肠道疾病:一项系统评价和荟萃分析。
New Microbes New Infect. 2021 Mar 16;41:100865. doi: 10.1016/j.nmni.2021.100865. eCollection 2021 May.
4
Lactobacillus rhamnosus JB3 inhibits Helicobacter pylori infection through multiple molecular actions.鼠李糖乳杆菌 JB3 通过多种分子作用抑制幽门螺杆菌感染。
Helicobacter. 2021 Jun;26(3):e12806. doi: 10.1111/hel.12806. Epub 2021 Apr 11.
5
Helicobacter pylori inhibits autophagic flux and promotes its intracellular survival and colonization by down-regulating SIRT1.幽门螺杆菌通过下调 SIRT1 抑制自噬流,促进其细胞内存活和定植。
J Cell Mol Med. 2021 Apr;25(7):3348-3360. doi: 10.1111/jcmm.16411. Epub 2021 Feb 28.
6
Current Applications of Bacteriocin.细菌素的当前应用
Int J Microbiol. 2020 Nov 3;2020:4374891. doi: 10.1155/2020/4374891. eCollection 2020.
7
Safety and Efficacy of Nitazoxanide-Based Regimen for the Eradication of Infection: A Systematic Review and Meta-Analysis.基于硝唑尼特的感染根除方案的安全性和有效性:一项系统评价与荟萃分析
Gastroenterology Res. 2020 Dec;13(6):260-268. doi: 10.14740/gr1342. Epub 2020 Dec 23.
8
An update on current and advancing pharmacotherapy options for the treatment of H. pylori infection.幽门螺杆菌感染治疗的当前和进展的药物治疗选择的更新。
Expert Opin Pharmacother. 2021 Apr;22(6):729-741. doi: 10.1080/14656566.2020.1845649. Epub 2020 Nov 12.
9
Helicobacter pylori infection and autoimmune diseases; Is there an association with systemic lupus erythematosus, rheumatoid arthritis, autoimmune atrophy gastritis and autoimmune pancreatitis? A systematic review and meta-analysis study.幽门螺杆菌感染与自身免疫性疾病;与系统性红斑狼疮、类风湿性关节炎、自身免疫性萎缩性胃炎和自身免疫性胰腺炎是否有关?系统评价和荟萃分析研究。
J Microbiol Immunol Infect. 2021 Jun;54(3):359-369. doi: 10.1016/j.jmii.2020.08.011. Epub 2020 Aug 28.
10
Effects of Multi-Strain Probiotics on Immune Responses and Metabolic Balance in -Infected Mice.多菌株益生菌对感染小鼠免疫应答和代谢平衡的影响。
Nutrients. 2020 Aug 17;12(8):2476. doi: 10.3390/nu12082476.